0 Bewertungen
ID

13238

Beschreibung

A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML; ODM derived from: https://clinicaltrials.gov/show/NCT02040506

Link

https://clinicaltrials.gov/show/NCT02040506

Stichworte

Versionen (1)
  1. 25.01.16 25.01.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

25. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Acute Myelogenous Leukemia NCT02040506

    Englisch

    Eligibility Acute Myelogenous Leukemia NCT02040506

    1 Formulare  
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    relapsed or treatment-refractory aml
    Beschreibung

    AML

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023467
    eastern cooperative oncology group status 0-2
    Beschreibung

    ECOG

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    life expectancy of at least 12 weeks
    Beschreibung

    life expectancy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    adequate baseline renal and hepatic function
    Beschreibung

    renal and hepatic function

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0232804
    UMLS CUI [2]
    C0232741
    measurable disease (eg, peripheral blasts greater than 5%)
    Beschreibung

    measurable disease

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    chronic myelogenous leukemia in blast crisis
    Beschreibung

    CML

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023474
    monoclonal therapy within 4 weeks, or chemotherapy or radiotherapy within 2 weeks
    Beschreibung

    monoclonal therapy or chemotherapy or radiotherapy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    UMLS CUI [2]
    C1522449
    UMLS CUI [3]
    C0279694
    unresolved acute toxicity from prior anti-cancer therapy
    Beschreibung

    toxicity

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0013221
    prior allogeneic stem cell transplant and active graft-versus-host disease requiring systemic immunosuppressive therapy within 15 days prior to screening
    Beschreibung

    stem cell transplant and graft-versus-host disease

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1504389
    UMLS CUI [2]
    C0018133
    history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
    Beschreibung

    allergic or anaphylactic reactions to monoclonal antibody therapy

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C0279694
    known current leptomeningeal or central nervous system (cns) involvement of leukemia
    Beschreibung

    cns leukemia

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1332884
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Eligibility Acute Myelogenous Leukemia NCT02040506

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    AML
    Item
    relapsed or treatment-refractory aml
    boolean
    C0023467 (UMLS CUI [1])
    ECOG
    Item
    eastern cooperative oncology group status 0-2
    boolean
    C1520224 (UMLS CUI [1])
    life expectancy
    Item
    life expectancy of at least 12 weeks
    boolean
    C0023671 (UMLS CUI [1])
    renal and hepatic function
    Item
    adequate baseline renal and hepatic function
    boolean
    C0232804 (UMLS CUI [1])
    C0232741 (UMLS CUI [2])
    measurable disease
    Item
    measurable disease (eg, peripheral blasts greater than 5%)
    boolean
    C1513041 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    CML
    Item
    chronic myelogenous leukemia in blast crisis
    boolean
    C0023474 (UMLS CUI [1])
    monoclonal therapy or chemotherapy or radiotherapy
    Item
    monoclonal therapy within 4 weeks, or chemotherapy or radiotherapy within 2 weeks
    boolean
    C0392920 (UMLS CUI [1])
    C1522449 (UMLS CUI [2])
    C0279694 (UMLS CUI [3])
    toxicity
    Item
    unresolved acute toxicity from prior anti-cancer therapy
    boolean
    C0013221 (UMLS CUI [1])
    stem cell transplant and graft-versus-host disease
    Item
    prior allogeneic stem cell transplant and active graft-versus-host disease requiring systemic immunosuppressive therapy within 15 days prior to screening
    boolean
    C1504389 (UMLS CUI [1])
    C0018133 (UMLS CUI [2])
    allergic or anaphylactic reactions to monoclonal antibody therapy
    Item
    history of severe allergic or anaphylactic reactions to monoclonal antibody therapy
    boolean
    C0020517 (UMLS CUI [1,1])
    C0279694 (UMLS CUI [1,2])
    cns leukemia
    Item
    known current leptomeningeal or central nervous system (cns) involvement of leukemia
    boolean
    C1332884 (UMLS CUI [1])
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video